Gastrointestinal pathogen test
Acutis Reveal™ gastrointestinal infection test (GIT) offers a new definition of certainty:
it's an FDA-approved test that can detect 14 major gastrointestinal pathogens.
This one-step, non-invasive stool test screens for infectious bacteria, viruses, and parasites in as few as 5 to 24 hours from the time the sample reaches our lab.
Molecular detection of infectious diseases
eases and expedites the process
Additional confirmation requirements
Subtype detection of pathogens
Number of pathogens tested
Acutis Reveal™ GIT
Within 24 hours of sample receipt
Ova & Parasite
Bacterial or viral only
Up to 3 days
The FDA-approved test detects
14 major gastrointestinal pathogens
Reveal™ GIT viral targets
Reveal™ GIT bacterial targets
Reveal™ GIT parasitic targets
Clostridium difficile toxins A & B
Enterotoxigenic E. coli (ETEC) LT/ST
Escherichia coli O157
Shiga-like Toxin producing E. coli (STEC) stx1/stx2
Benefits of Acutis Reveal™ GIT at a glance
Simultaneous detection and identification of >90% of the bacteria, viral and parasitic pathogens responsible for infectious diarrhea
Breakthrough technology confirms a 99% Negative Predictive Value, encouraging best-practice treatment and patient care
Delivery of 95% of results the same day we receive the sample
Prevention of misdiagnoses and subsequent inappropriate use of antibiotics and other potentially costly actions
Minimal sample required for testing
Reveal™ GIT determines whether or not cases of diarrhea are infectious
Acutis Reveal™ gastrointestinal pathogen test can identify pathogens faster and with greater accuracy than any traditional methods or procedures. Highly accurate, the test detects and identifies >90% of infectious agents, providing the certainty clinicians require to provide the most efficient and efficacious patient care, in the shortest amount of time.
Gastroenteritis is a growing problem. It too often frustrates the attending physician, always punishes the patient, and frequently puts others at risk.
Acutis Reveal™ offers a novel, proven, state-of-the-art technique that both diagnoses gastroenteritis while identifying specific viral, bacterial, or parasitic pathogens.
Reveal™ GIT determines the therapeutic course of action
The test quickly determines the specific bacteria, viral and parasitic pathogens causing the illness. With this knowledge, a medical provider can then take a more specific course of action. For example, if the bacterial toxin is identified as E. coli (STEC) or Shiga-like Toxin, the use of antibiotics may be appropriate. However, if it proves to be a case of Clostridium difficile toxins A and B, swift action may be called for due to its contagious nature.
For certain other patients, such as those with IBD, the ability to rule out infections is especially useful. In recent times, these particular pathogens have become notorious as they become better known to the general public.
Our test goes some way to ascertain a diagnosis, while calming the patients’ anxiety.
If you have any questions about the
Acutis Reveal™ gastrointestinal tests
Our molecular disease relations experts are available to speak with you to provide the information you need, to make individual test selections, based on your diagnoses and medical necessity.